#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with Expression


Single nucleotide polymorphisms (SNPs) on chromosome 9p21 are associated with coronary artery disease, diabetes, and multiple cancers. Risk SNPs are mainly non-coding, suggesting that they influence expression and may act in cis. We examined the association between 56 SNPs in this region and peripheral blood expression of the three nearest genes CDKN2A, CDKN2B, and ANRIL using total and allelic expression in two populations of healthy volunteers: 177 British Caucasians and 310 mixed-ancestry South Africans. Total expression of the three genes was correlated (P<0.05), suggesting that they are co-regulated. SNP associations mapped by allelic and total expression were similar (r = 0.97, P = 4.8×10−99), but the power to detect effects was greater for allelic expression. The proportion of expression variance attributable to cis-acting effects was 8% for CDKN2A, 5% for CDKN2B, and 20% for ANRIL. SNP associations were similar in the two populations (r = 0.94, P = 10−72). Multiple SNPs were independently associated with expression of each gene (P<0.05 after correction for multiple testing), suggesting that several sites may modulate disease susceptibility. Individual SNPs correlated with changes in expression up to 1.4-fold for CDKN2A, 1.3-fold for CDKN2B, and 2-fold for ANRIL. Risk SNPs for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of ANRIL (all P<0.05 after correction for multiple testing), while association with the other two genes was only detectable for some risk SNPs. SNPs had an inverse effect on ANRIL and CDKN2B expression, supporting a role of antisense transcription in CDKN2B regulation. Our study suggests that modulation of ANRIL expression mediates susceptibility to several important human diseases.


Vyšlo v časopise: Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with Expression. PLoS Genet 6(4): e32767. doi:10.1371/journal.pgen.1000899
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1000899

Souhrn

Single nucleotide polymorphisms (SNPs) on chromosome 9p21 are associated with coronary artery disease, diabetes, and multiple cancers. Risk SNPs are mainly non-coding, suggesting that they influence expression and may act in cis. We examined the association between 56 SNPs in this region and peripheral blood expression of the three nearest genes CDKN2A, CDKN2B, and ANRIL using total and allelic expression in two populations of healthy volunteers: 177 British Caucasians and 310 mixed-ancestry South Africans. Total expression of the three genes was correlated (P<0.05), suggesting that they are co-regulated. SNP associations mapped by allelic and total expression were similar (r = 0.97, P = 4.8×10−99), but the power to detect effects was greater for allelic expression. The proportion of expression variance attributable to cis-acting effects was 8% for CDKN2A, 5% for CDKN2B, and 20% for ANRIL. SNP associations were similar in the two populations (r = 0.94, P = 10−72). Multiple SNPs were independently associated with expression of each gene (P<0.05 after correction for multiple testing), suggesting that several sites may modulate disease susceptibility. Individual SNPs correlated with changes in expression up to 1.4-fold for CDKN2A, 1.3-fold for CDKN2B, and 2-fold for ANRIL. Risk SNPs for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of ANRIL (all P<0.05 after correction for multiple testing), while association with the other two genes was only detectable for some risk SNPs. SNPs had an inverse effect on ANRIL and CDKN2B expression, supporting a role of antisense transcription in CDKN2B regulation. Our study suggests that modulation of ANRIL expression mediates susceptibility to several important human diseases.


Zdroje

1. The Wellcome Trust Case Control Consortium 2007 Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 661 678

2. HelgadottirA

ThorleifssonG

ManolescuA

GretarsdottirS

BlondalT

2007 A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction. Science 316 1491 1493

3. McPhersonR

PertsemlidisA

KavaslarN

StewartA

RobertsR

2007 A common allele on chromosome 9 associated with coronary heart disease. Science 316 1488 1491

4. SamaniNJ

ErdmannJ

HallAS

HengstenbergC

ManginoM

2007 Genomewide association analysis of coronary artery disease. N Engl J Med 357 443 453

5. GschwendtnerA

BevanS

ColeJW

PlourdeA

MatarinM

2009 Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Annals of Neurology 65 531 539

6. MatarinM

BrownWM

SingletonA

HardyJA

MeschiaJF

2008 Whole Genome Analyses Suggest Ischemic Stroke and Heart Disease Share an Association With Polymorphisms on Chromosome 9p21. Stroke 39 1586 1589

7. HelgadottirA

ThorleifssonG

MagnussonKP

GretarsdottirS

SteinthorsdottirV

2008 The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 40 217 224

8. ZegginiE

WeedonMN

LindgrenCM

FraylingTM

ElliottKS

2007 Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316 1336 1341

9. ScottLJ

MohlkeKL

BonnycastleLL

WillerCJ

LiY

2007 A genome-wide association study of type 2 diabetes in finns detects multiple susceptibility variants. Science 316 1341 1345

10. SheteS

HoskingFJ

RobertsonLB

DobbinsSE

SansonM

2009 Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41 899 904

11. WrenschM

JenkinsRB

ChangJS

YehR-F

XiaoY

2009 Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41 905 908

12. BishopDT

DemenaisF

IlesMM

HarlandM

TaylorJC

2009 Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 41 920 925

13. DebniakT

GorskiB

HuzarskiT

ByrskiT

CybulskiC

2005 A common variant of CDKN2A (p16) predisposes to breast cancer. J Med Genet 42 763 765

14. DriverKE

SongH

LesueurF

AhmedS

Barbosa-MoraisNL

2008 Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis 29 333 341

15. GaytherSA

SongH

RamusSJ

KjaerSK

WhittemoreAS

2007 Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Research 67 3027 3035

16. ChenJ

LiD

WeiC

SenS

KillaryAM

2007 Aurora-A and p16 Polymorphisms Contribute to an Earlier Age at Diagnosis of Pancreatic Cancer in Caucasians. Clin Cancer Res 13 3100 3104

17. KumarR

SmedsJ

BerggrenP

StraumeO

RozellBL

2001 A single nucleotide polymorphism in the 3′untranslated region of the CDNK2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and P53 genes are rare. International Journal of Cancer 95 388 393

18. HealyJ

BélangerH

BeaulieuP

LarivièreM

LabudaD

2007 Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia. Blood 109 683 692

19. MelzerD

FraylingTM

MurrayA

HurstAJ

HarriesLW

2007 A common variant of the p16INK4a genetic region is associated with physical function in older people. Mechanisms of Ageing and Development 128 370 377

20. Griffiths-JonesS

SainiHK

van DongenS

EnrightAJ

2008 miRBase: tools for microRNA genomics. Nucl Acids Res 36 D154 158

21. RheadB

KarolchikD

KuhnRM

HinrichsAS

ZweigAS

The UCSC Genome Browser database: update 2010. Nucl Acids Res 38 D613 619

22. The UCSC Genome Bioinformatics database

23. miRBase: the microRNA database

24. HussussianCJ

StruewingJP

GoldsteinAM

HigginsPAT

AllyDS

1994 Germline p16 mutations in familial melanoma. Nat Genet 8 15 21

25. GilJ

PetersG

2006 Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7 667 677

26. HaraE

SmithR

ParryD

TaharaH

StoneS

1996 Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Molecular and Cellular Biology 16 859 867

27. WangX

FengY

PanL

WangY

XuX

2007 The proximal GC-rich region of p16INK4a gene promoter plays a role in its transcriptional regulation. Molecular and Cellular Biochemistry 301 259 266

28. WangW

WuJ

ZhangZ

TongT

2001 Characterization of Regulatory Elements on the Promoter Region of p16INK4a That Contribute to Overexpression of p16 in Senescent Fibroblasts. J Biol Chem 276 48655 48661

29. RobertsonKD

JonesPA

1998 The Human ARF Cell Cycle Regulatory Gene Promoter Is a CpG Island Which Can Be Silenced by DNA Methylation and Down-Regulated by Wild-Type p53. Mol Cell Biol 18 6457 6473

30. GonzalezS

KlattP

DelgadoS

CondeE

Lopez-RiosF

2006 Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 440 702 706

31. KimWY

SharplessNE

2006 The Regulation of INK4/ARF in Cancer and Aging. Cell 127 265 275

32. MercerTR

DingerME

MattickJS

2009 Long non-coding RNAs: insights into functions. Nat Rev Genet 10 155 159

33. SchadtEE

MonksSA

DrakeTA

LusisAJ

CheN

2003 Genetics of gene expression surveyed in maize, mouse and man. Nature 422 297 302

34. PastinenT

HudsonTJ

2004 Cis-acting regulatory variation in the human genome. Science 306 647 650

35. BroadbentHM

PedenJF

LorkowskiS

GoelA

OngenH

2008 Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 17 806 814

36. JarinovaO

StewartAFR

RobertsR

WellsG

LauP

2009 Functional Analysis of the Chromosome 9p21.3 Coronary Artery Disease Risk Locus. Arterioscler Thromb Vasc Biol 29 1671 1677

37. LiuY

SanoffHK

ChoH

BurdCE

TorriceC

2009 INK4/ARF Transcript Expression Is Associated with Chromosome 9p21 Variants Linked to Atherosclerosis. PLoS ONE 4 e5027 doi:10.1371/journal.pone.0005027

38. FolkersenL

KyriakouT

GoelA

PedenJ

MälarstigA

2009 Relationship between CAD Risk Genotype in the Chromosome 9p21 Locus and Gene Expression. Identification of Eight New ANRIL Splice Variants. PLoS ONE 4 e7677 doi:10.1371/journal.pone.0005027

39. CampbellMC

TishkoffSA

2008 African Genetic Diversity: Implications for Human Demographic History, Modern Human Origins, and Complex Disease Mapping. Annual Review of Genomics and Human Genetics 9 403 433

40. SilanderK

TangH

MylesS

JakkulaE

TimpsonNJ

2009 Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease. Genome Medicine 1 51.51 51.57

41. McKenzieCA

AbecasisGR

KeavneyB

ForresterT

RatcliffePJ

2001 Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet 10 1077 1084

42. CampinoS

FortonJ

RajS

MohrB

AuburnS

2008 Validating Discovered Cis-Acting Regulatory Genetic Variants: Application of an Allele Specific Expression Approach to HapMap Populations. PLoS ONE 3 e4105 doi:10.1371/journal.pone.0004105

43. ChenJ

LiD

KillaryA

SenS

AmosC

2009 Polymorphisms of p16, p27, p73, and MDM2 Modulate Response and Survival of Pancreatic Cancer Patients Treated with Preoperative Chemoradiation. Annals of Surgical Oncology 16 431 439

44. DębniakT

CybulskiC

GórskiB

HuzarskiT

ByrskiT

2007 CDKN2A-positive breast cancers in young women from Poland. Breast Cancer Research and Treatment 103 355 359

45. YanL

NaW

ShanK

Xiao-WeiM

WeiG

2008 p16(CDKN2) gene polymorphism: Association with histologic subtypes of epithelial ovarian cancer in China. International Journal of Gynecological Cancer 18 30 35

46. SakanoS

BerggrenP

KumarR

SteineckG

AdolfssonJ

2003 Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene. International Journal of Cancer 104 98 103

47. DebniakT

ScottRJ

HuzarskiT

ByrskiT

RozmiarekA

2005 CDKN2A Common Variants and Their Association with Melanoma Risk: A Population-Based Study. Cancer Res 65 835 839

48. StraumeO

SmedsJ

KumarR

HemminkiK

AkslenLA

2002 Significant Impact of Promoter Hypermethylation and the 540 C>T Polymorphism of CDKN2A in Cutaneous Melanoma of the Vertical Growth Phase. Am J Pathol 161 229 237

49. PasmantE

LaurendeauI

HeronD

VidaudM

VidaudD

2007 Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL, an Antisense Noncoding RNA Whose Expression Coclusters with ARF. Cancer Res 67 3963 3969

50. YuW

GiusD

OnyangoP

Muldoon-JacobsK

KarpJ

2008 Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451 202 206

51. YangMQ

KoehlyLM

ElnitskiLL

2007 Comprehensive Annotation of Bidirectional Promoters Identifies Co-Regulation among Breast and Ovarian Cancer Genes. PLoS Comput Biol 3 e72 doi:10.1371/journal.pcbi.0030072

52. TeareMD

HeighwayJ

Santibanez KorefMF

2006 An Expectation-Maximization Algorithm for the Analysis of Allelic Expression Imbalance. Am J Hum Genet 79 539 543

53. LiuY

SanoffHK

ChoH

BurdCE

TorriceC

2009 Expression of p16INK4a in peripheral blood T-cells is a biomarker of human aging. Aging Cell 8 439 448

54. ManolioTA

BrooksLD

CollinsFS

2008 A HapMap harvest of insights into the genetics of common disease. Journal of Clinical Investigation 118 1590 1605

55. LalA

KimHH

AbdelmohsenK

KuwanoY

PullmannRJr

2008 p16INK4a Translation Suppressed by miR-24. PLoS ONE 3 e1864 doi:10.1371/journal.pone.0001864

56. StrangerBE

NicaAC

ForrestMS

DimasA

BirdCP

2007 Population genomics of human gene expression. Nat Genet 39 1217 1224

57. DixonAL

2007 A genome-wide association study of global gene expression. Nat Genet 39 1202 1207

58. PlagnolV

UzE

WallaceC

StevensH

ClaytonD

2008 Extreme Clonality in Lymphoblastoid Cell Lines with Implications for Allele Specific Expression Analyses. PLoS ONE 3 e2966 doi:10.1371/journal.pone.0002966

59. PastinenT

SladekR

GurdS

SammakA

GeB

2004 A survey of genetic and epigenetic variation affecting human gene expression. Physiological Genomics 16 184 193

60. GimelbrantA

HutchinsonJN

ThompsonBR

ChessA

2007 Widespread Monoallelic Expression on Human Autosomes. Science 318 1136 1140

61. CirulliET

GoldsteinDB

2007 In vitro assays fail to predict in vivo effects of regulatory polymorphisms. Hum Mol Genet 16 1931 1939

62. ZhangK

LiJB

GaoY

EgliD

XieB

2009 Digital RNA allelotyping reveals tissue-specific and allele-specific gene expression in human. Nature Methods 6 613 618

63. The Cancer Genome Atlas Research Network 2008 Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 1061 1068

64. ParsonsDW

JonesS

ZhangX

LinJC-H

LearyRJ

2008 An Integrated Genomic Analysis of Human Glioblastoma Multiforme. Science 321 1807 1812

65. BerwickM

OrlowI

HummerAJ

ArmstrongBK

KrickerA

2006 The Prevalence of CDKN2A Germ-Line Mutations and Relative Risk for Cutaneous Malignant Melanoma: An International Population-Based Study. Cancer Epidemiology Biomarkers & Prevention 15 1520 1525

66. GoldsteinAM

ChanM

HarlandM

HaywardNK

DemenaisF

2007 Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents. Journal of Medical Genetics 44 99 106

67. KrishnamurthyJ

RamseyMR

LigonKL

TorriceC

KohA

2006 p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443 453 457

68. MoritaniM

YamasakiS

KagamiM

SuzukiT

YamaokaT

2005 Hypoplasia of endocrine and exocrine pancreas in homozygous transgenic TGF-beta1. Molecular and Cellular Endocrinology 229 175 184

69. AndreassiM

2008 DNA damage, vascular senescence and atherosclerosis. Journal of Molecular Medicine 86 1033 1043

70. MinaminoT

KomuroI

2007 Vascular Cell Senescence: Contribution to Atherosclerosis. Circ Res 100 15 26

71. ZegginiE

ScottLJ

SaxenaR

VoightBF

MarchiniJL

2008 Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40 638 645

72. DuesingK

FatemifarG

CharpentierG

MarreM

TichetJ

2008 Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids. Diabetologia 51 821 826

73. KangMY

LeeBB

JiYI

JungEH

ChunH-K

2008 Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer. Cancer 112 1699 1707

74. ZüchnerS

GilbertJR

MartinER

Leon-GuerreroCR

XuPT

2008 Linkage and Association Study of Late-Onset Alzheimer Disease Families Linked to 9p21.3. Annals of Human Genetics 72 725 731

75. LiJ-M

NicholsMA

ChandrasekharanS

XiongY

WangX-F

1995 Transforming Growth Factor beta Activates the Promoter of Cyclin-dependent Kinase Inhibitor p15 (INK4B) through an Sp1 Consensus Site. J Biol Chem 270 26750 26753

76. MesseguerX

EscuderoR

FarreD

NunezO

MartinezJ

2002 PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18 333 334

77. FarreD

RosetR

HuertaM

AdsuaraJE

RoselloL

2003 Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucl Acids Res 31 3651 3653

78. RozenS

SkaletskyHJ

2000 Primer3 on the WWW for general users and for biologist programmers.

MisenerS

KrawetzSA

Bioinformatics Methods and Protocols: Methods in Molecular Biology Totowa, NJ Humana Press 365 386

79. VandesompeleJ

De PreterK

PattynF

PoppeB

Van RoyN

2002 Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 3 research0034.0031 research0034.0011

80. ZhangX

DingL

SandfordAJ

2005 Selection of reference genes for gene expression studies in human neutrophils by real-time PCR. BMC Molecular Biology 6

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2010 Číslo 4
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#